BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14991403)

  • 1. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma.
    Ito R; Nakayama H; Yoshida K; Matsumura S; Oda N; Yasui W
    Virchows Arch; 2004 Apr; 444(4):324-31. PubMed ID: 14991403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance.
    Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL
    Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
    Czyzewska J; Guzinska-Ustymowicz K; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer.
    Jin EH; Lee DH; Jung SA; Shim KN; Seo JY; Kim N; Shin CM; Yoon H; Jung HC
    World J Gastroenterol; 2015 Jan; 21(2):571-7. PubMed ID: 25593477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.
    Zheng HC; Xu XY; Xia P; Yu M; Takahashi H; Takano Y
    Hum Pathol; 2010 Sep; 41(9):1255-64. PubMed ID: 20447678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
    Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
    BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Virchows Arch; 2008 Feb; 452(2):147-55. PubMed ID: 18080135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
    Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.
    Zhang JB; Zhang B; Guo L; Lin ZH; Li XQ; Guo K; Sun HC; Ye QH
    Oncotarget; 2015 Nov; 6(37):40223-34. PubMed ID: 26474280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
    Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
    Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma.
    Zhao P; Lu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(5):5230-5. PubMed ID: 26191222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
    Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.
    Anagnostopoulos GK; Stefanou D; Arkoumani E; Chalkley L; Karagiannis J; Paraskeva K; Mathou N; Dellaporta E; Tsianos E; Agnantis NJ
    Acta Gastroenterol Belg; 2007; 70(3):285-9. PubMed ID: 18074738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells.
    Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y
    Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.